Is a Full-Body MRI Worth It? What Comprehensive Screening Actually Finds

When a full-body MRI is worth it: the evidence in brief

A full-body MRI is worth it for a small group of people and, on present evidence, not for most. Screening earns its place when finding a disease early leads to longer or better lives, and for whole-body MRI in people without symptoms that has not been shown: a 2026 review in Canadian Family Physician found no randomised trial comparing people screened this way with people who were not.

What the studies do show is how often the scan finds something. Pooled data from 12 studies of 5,373 adults without symptoms found a critical or indeterminate incidental finding in 32.1 per cent (Kwee and Kwee, 2019). A meta-analysis of 10 studies with 9,024 participants, published in 2025, put the rate of confirmed cancer at 1.57 per cent (Martins da Fonseca and colleagues, European Radiology). Most of what the scan finds is therefore not cancer, and each finding still needs a decision.

Professional bodies read the evidence the same way. The American College of Radiology said in April 2023 that there is not enough evidence to recommend total-body screening for people without symptoms, risk factors or a family history suggesting disease, and that it is concerned such screening will lead to unnecessary follow-up tests. The Swiss Society of Radiology (SGR-SSR) takes a critical view of whole-body MRI in people without a clinical indication, and the Canadian review concluded that it should not be encouraged.

What full-body MRI, full-body CT and a check-up actually are

A full-body MRI images the brain, neck, chest, abdomen, pelvis and spine in one session, with some packages adding further regions, and it uses no ionising radiation (US FDA). The Swiss screening scans described here use no contrast dye. One Zurich radiology institute describes its whole-body MRI as a contrast-free screening examination taking 30 to 60 minutes including positioning, and the Swiss provider Ahead Health gives about 30 to 60 minutes in the scanner depending on the package.

A whole-body MRI is not a set of targeted scans. The SGR-SSR notes that legal limits on body heating and the time a person can lie in the scanner mean its resolution and image quality are not comparable with a targeted MRI. Coverage also varies by package: one UK provider's standard scans leave out the hips, prostate, gynaecological pelvis and breasts, and the authors of a study of 576 adults concluded that whole-body MRI may be inadequate for detecting colon, thyroid and breast cancers (Basar and colleagues, 2021).

A full-body CT uses X-rays, and the FDA notes that the radiation exposure of a CT examination can be several hundred times that of a chest X-ray. A comprehensive check-up is broader and less defined. At Clinique de Genolier, for example, the check-up combines specialist consultations, laboratory tests and examinations over one to three days, tailored to family history, medical risks and age. The NHS offers the NHS Health Check, which it describes as a check-up of heart and blood vessel health: blood pressure, cholesterol, weight and a risk assessment for heart disease, stroke, diabetes and kidney disease, every five years for adults aged 40 to 74 without certain existing conditions.

How often a full-body scan finds something

Almost always, if the question is whether the report will mention anything. One systematic review of 12 studies with 6,214 whole-body MRI examinations, summarised in Canadian Family Physician, found at least one finding in about 94 per cent of adults without symptoms and further investigation in 30 per cent (Zugni and colleagues, 2020). For whole-body CT, a study of 1,192 people at a community screening centre found at least one abnormal finding in 86 per cent, with 2.8 findings per person on average, and a recommendation for further evaluation in 37 per cent (Furtado and colleagues, Radiology, 2005).

The pattern holds across imaging generally. An umbrella review of 20 systematic reviews in the BMJ found incidental findings in 22 per cent of brain and of spine MRI scans and in more than a third of cardiac MRI and chest CT scans. How often such a finding proves to be cancer depends on the organ: under 5 per cent in the brain, parotid gland and adrenal gland, around a quarter in the kidney, thyroid and ovary, and 42 per cent in the breast.

False positives and the cascade of further tests

A false positive is a finding that looks like disease and is not. In the six whole-body MRI studies that reported them, false positives made up a pooled 16.0 per cent of all critical and indeterminate findings, with a confidence interval of 1.9 to 65.8 per cent, and the reviewers noted that verification data were lacking. The FDA makes the same point about whole-body CT: being told of an abnormality when nothing significant is wrong is far more likely than the discovery of a life-threatening disease.

Each finding can start a chain of repeat scans, different scans, specialist visits and sometimes a biopsy. In a national survey of 376 US internists, 99.4 per cent reported experiencing such cascades after incidental findings; 68.4 per cent said cascades had caused their patients psychological harm, 57.5 per cent financial burden and 15.6 per cent physical harm (Ganguli and colleagues, 2019).

False reassurance is the other side. In the study of 576 adults above, 16 participants had false-negative results, five of them cancers. The American College of Radiology warned as early as 2002 that whole-body CT screening would lead to findings that do not affect health but result in unnecessary examinations, treatments and expense.

Radiation and Swiss law: why a full-body CT is a different decision

MRI uses no ionising radiation; CT does. The FDA estimates that a CT examination with an effective dose of 10 millisieverts may add approximately 1 chance in 2,000 of a fatal cancer, against a natural risk of about 400 in 2,000 in the US population. For whole-body CT specifically, a 2004 analysis in Radiology estimated that one scan at age 45 carries a lifetime cancer mortality risk of around 0.08 per cent, and annual scans from 45 to 75 about 1.9 per cent.

Swiss law treats this as more than a personal choice. The Radiological Protection Ordinance of 26 April 2017, in force since 1 January 2018 and last amended on 1 July 2026, defines radiological screening as an examination of a group of people for the early detection of a disease that is not clinically suspected, and allows it only as part of a programme instituted by a health authority (Article 30). Every individual examination must be justified in advance by the physician who performs it (Article 29).

The ordinance protects against ionising radiation, which MRI does not use, and so does not restrict whole-body MRI in the same way. Low-dose CT still has a place: the SGR-SSR lists low-dose CT for smokers, alongside colonoscopy and mammography, among the more sensible alternatives to a whole-body MRI.

Where whole-body MRI is recommended

Whole-body MRI has a clear role in people with a high inherited cancer risk. For Li-Fraumeni syndrome, caused by harmful variants in the TP53 gene, the European Reference Network GENTURIS guidelines recommend a yearly clinical examination and whole-body MRI for adult carriers, with breast MRI for women from 20 to 65 and brain MRI until 50 (Frebourg and colleagues, 2020).

The yield in this group is of a different order. A meta-analysis of 578 carriers from 13 cohorts in six countries found 42 cancers in 39 people at the first whole-body MRI, 35 of them new localised cancers treated with curative intent, a detection rate for new localised primary cancers of 7 per cent (Ballinger and colleagues, JAMA Oncology, 2017).

Radiologists have written reporting rules for this use: the ONCO-RADS guidelines set out how whole-body MRI for cancer screening in people at higher risk should be acquired and reported, with five assessment categories. For other defined risk groups, Swiss basic insurance pays for targeted surveillance instead, such as mammography or breast MRI, chosen by risk and age, for women with a moderately or highly increased familial risk, organised through certified breast centres, and genetic counselling for listed hereditary cancer syndromes (Health Insurance Benefits Ordinance, Article 12d).

Screening with proven benefit, and what Swiss insurance pays

The screening that has earned its place is organised, targeted and repeated. The Federal Health Insurance Act (Article 26) obliges basic insurance to pay for specific early-detection examinations, and the Health Insurance Benefits Ordinance, in its version of 1 August 2026, lists them.

Swiss Cancer Screening harmonises and quality-assures the cantonal programmes and lists which cantons offer them. A preventive whole-body MRI is not among the examinations the ordinance lists; one provider states that some supplementary insurers refund part of the cost.

General check-ups are a separate question. A Cochrane review of randomised trials found that general health checks in adults have little or no effect on total mortality (risk ratio 1.00 across 11 trials with 233,298 participants) or on cancer mortality, and probably little or none on cardiovascular mortality. How screening priorities shift with age is the subject of our note on the executive health check after fifty.

Full-body MRI cost in Switzerland, the UK and the US

The prices below are those the providers publish themselves. The Swiss packages listed ranged on 22 September 2026 from CHF 1,990, with a report and a doctor's consultation included, to CHF 3,549 for a package that adds blood tests and further imaging.

Two cautions apply when reading the table. In these packages, a lower price buys fewer body regions or leaves out the consultation, so compare what is scanned and who reads it. And the SGR-SSR reminds patients that a high price does not automatically mean quality, and suggests asking where the money goes. For medical costs in Switzerland more broadly, see what Swiss treatment costs, and for published check-up prices at longevity clinics, our guide to longevity clinic costs.

What happens after an unexpected finding

Most findings end in reassurance, but the route there matters. Radiology societies write follow-up rules precisely to stop low-risk findings turning into long chains of tests: the American College of Radiology notes that where guidance on management is missing, very low-risk incidental findings risk over-testing and over-treatment.

How to decide whether to book a full-body scan

The decision turns on your own risk, on what you would do with the result and on what else the money could buy. The SGR-SSR's advice to patients starts with the question of whether the scan is really necessary, and it recommends asking your own doctor to suggest an institute if you go ahead.

The FDA lists metal objects drawn into the magnet, implants and heating among the main MRI safety risks. If you would like the options set out, we can put the published figures and the options in our network in front of you, including precision diagnostics at Calda Clinic in Zurich and the check-up at Clinique de Genolier, and we will say so when screening through your own doctor at home is the better answer. Write to us with your age, family history and what you want to find out.

Sources

Laws are cited in the version in force on 22 September 2026. Prices are those providers published on that date; treat them as starting points, not quotations.